- ￥600 - 1600
- Abbiotec
- 美国
- 350296
- 2025年07月15日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件：
Store at -20°C. The product is hygroscopic and must be protected from light. Product is guaranteed one year from the date of shipment. Following reconstitution, aliquot and store at -20°C.
- 保质期：
参照说明书可保存1-2年
- 英文名：
Neurotensin Peptide (Guinea Pig)
- 库存：
一定量库存
- 供应商：
华拓生物
- 规格：
2 mg
| 产品名称： | Neurotensin Peptide (Guinea Pig) |
| 产品链接： | http://www.abbiotec.com/peptides/neurotensin-peptide-%252528guinea-pig%252529 |
| 货号： | 350296 |
| 规格： | 2 mg |
| 产品描述： | Neurotensin may play an endocrine or paracrine role in the regulation of fat metabolism. It causes contraction of smooth muscles. |
| 序列： | Guinea Pig: H-pGlu-Leu-Tyr-Glu-Asn-Lys-Ser-Arg-Arg-Pro-Tyr-Ile-Leu-OH or H-pELYENKSRRPYIL-OH |
| 分子式： | C76H119N21O21 |
| 分子量： | 1662.92 g/mol |
| 纯度： | Purity > 95% by HPLC |
| 别名： | Neurotensin; NT; NTS |
| 形态： | Each vial contains 1 mg of lyophilized solid packaged under an inert gas and supplied as a trifluoroacetate salt. |
| 溶解方法： | Distilled water for a solution up to 2 mg/ml, otherwise we recommend using acetonitrile. |
| 保存方法： | Store at -20°C. The product is hygroscopic and must be protected from light. Product is guaranteed one year from the date of shipment. Following reconstitution, aliquot and store at -20°C. |
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Characterization of Neurotensin Receptors
, D., Le Fur, G., and Kitabgi, P. 1994. Effect of the nonpeptide neurotensin antagonist SR 48692 and two enantiomeric analogs SR 48527 and SR 49711 on neurotensin binding and contractile responses in guinea‐pig ileum and colon. J. Pharm. Exp. Ther. 271
disease virus (FMDV) in 1982, with the guinea pig as a laboratory animal model (3 , 4 ).
Harvesting, Isolation, and Functional Assessment of Primary Vagal Ganglia Cells
are protocols for harvesting guinea pig, mouse, and rat sensory nerve cell bodies to assess molecular and functional changes associated with pulmonary disease, and to identify new targets for therapeutic intervention. Curr. Protoc. Pharmacol . 62:12.15.1?12.15
技术资料暂无技术资料 索取技术资料
